Clinical trials: Suffering
Low Back Pain
Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back Pain
Primary Objective: To assess the efficacy of the infrared therapy patch (ITP) FIRTECH for treating participants suffering from mild to moderate acute low back pain.
- Trial name
- IRPATCH (NCT05137041)
- Testing
- ITP FIRTECH
- Where
- 7 sites in Germany, Italy
- Volunteers
- 221 people
- Sponsor
- Sanofi
Cancer, Pain
Relation Between Substance Use and Pain, in Patients Suffering or Surviving From Cancer and Followed in France
Pain is one of the most prevalent symptoms during and after cancer. Pain can be the consequence of several situations (disease progression, surgery, and anticancer drugs).
- Conditions
- Cancer, Pain, Substance Use
- Trial name
- CAPS (NCT05684939)
- Testing
- Questionnaire (patient reported outcome)
- Where
- France
- Volunteers
- 2,010 people
- Sponsor
- University Hospital, Clermont-Ferrand
Vasomotor Symptoms
A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women
A randomized, double-blind, placebo-controlled phase 2 clinical study to evaluate the efficacy and safety of HS-10384 in postmenopausal women suffering from vasomotor symptoms.
- Trial name
- NCT06393673
- Testing
- HS-10384 tablet Dose 1, HS-10384 tablet Dose 2
- Where
- China
- Volunteers
- 195 people
- Sponsor
- Hansoh BioMedical R&D Company
Bipolar Disorder
VALID : VAlproate Versus LIthium in Bipolar Disorders
Primary Objective : To compare the efficacy of valproate to lithium in Bipolar I patients suffering from a manic or a mixed episode according to DSM IV TR (APA 2000) [Diagnostic and Statistical Manual of Mental Disorders (DSM)…
- Trial name
- NCT00264173
- Testing
- Valproate sodium
- Volunteers
- 270 people
- Sponsor
- Sanofi
Multi Organ Failure
Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ Failure
A multicenter, randomized (1:1, iloprost: placebo), placebo controlled, blinded, investigator-initiated phase 2b trial in trauma patients with haemorrhagic shock and shock induced endotheliopathy (SHINE), investigating the…
- Trial name
- SHINE-TRAUMA (NCT03903939)
- Testing
- Iloprost, Isotonic saline
- Where
- 5 sites in Denmark, Norway
- Volunteers
- 228 people
- Sponsor
- Pär Johansson
Allergic Rhinoconjunctivitis
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis
As the principal objective of this study is to evaluate the efficacy and safety of the treatment measuring the changes in a symptom score, the patient will be asked to fill in a patient diary.
- Trial name
- GPIT (NCT00550875)
- Testing
- Grass pollen allergenic extract (L. perenne-C. dactylon )
- Where
- South Africa
- Volunteers
- 90 people
- Sponsor
- Laboratorios Leti, S.L.
Clear Cell RCC
A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma
This is an open label, single-centre phase 1/2 study involving a single dose of Temferon, an investigational Advanced Therapy Medicinal Product (ATMP), to treat patients with metastatic clear cell renal cell carcinoma (RCC) with…
- Trial name
- TEM-GU (NCT06716853)
- Testing
- Temferon, Pembrolizumab, Cabozantinib
- Where
- Italy
- Volunteers
- 10 people
- Sponsor
- Genenta Science
Psychological Distress, COVID
COVID-19 Pandemic Burden in Severe Mental Disease Patients
Despite being originated in Wuhan, in the China mainland region of the Hubei, Italy has been the hardest-hit country in the world by the COVID-19 pandemic during the month of March.
- Conditions
- Psychological Distress, COVID, Severe Mental Disorder
- Trial name
- PsyCOVID (NCT04357769)
- Testing
- PSS (Perceived Stress Scale), GAD-7 (7-item Generalized Anxiety Disorder), PHQ-9 (9-item Patient Health Questionnaire)
- Where
- Italy
- Volunteers
- 400 people
- Sponsor
- Federico II University
Food Addiction, Obesity
Validation of a Food Addiction Screening Test
Food addiction (FA) is a behavioral addiction characterized by a high consumption of palatable foods, which markedly activate the reward system, despite adverse consequences.
- Trial name
- FAST - FR (NCT04126239)
- Testing
- Online survey - questionnaire
- Where
- France
- Volunteers
- 1,610 people, healthy volunteers welcome
- Sponsor
- Hospices Civils de Lyon
Migraine
Randomized Trial to Evaluate the Effectiveness of a Mindfulness Based Intervention (MBSR) for Patients Suffering From Migraine
Patients suffering from migraine will be randomly allocated to one of two different behavioral interventions: mindfulness based stress reduction (MBSR) an eight week intervention program based different meditation \& yoga…
- Trial name
- NCT00826475
- Testing
- Mindfulness Based Stress Reduction MBSR, Psychoeducation
- Where
- Germany
- Volunteers
- 62 people
- Sponsor
- University Hospital Freiburg
ENT Cancer
Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress
Escitalopram is an antidepressant inhibitor of the serotonin reuptake. On the market in France since 2002. Prevalence of emotional distress in patients with cancer is 30-50%.
- Trial name
- TADDOR (NCT02246244)
- Testing
- Escitalopram
- Where
- France
- Volunteers
- 38 people
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
Neuroendocrine Carcinomas
Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer
Poorly differentiated neuroendocrine carcinomas (NEC) are a sub-group of aggressive neuroendocrine neoplasms (NEN). The most common primary sites are broncho-pulmonary and digestive.
- Trial name
- BEVANEC (NCT02820857)
- Testing
- Folfiri-bevacizumab, Folfiri
- Where
- 26 sites in France
- Volunteers
- 153 people
- Sponsor
- Hospices Civils de Lyon
Parkinson Disease Psychosis
Hallucinations in Parkinson's Disease
Investigation on how robotically mediated sensorimotor stimulation induces and triggers presence hallucinations in different clinical groups of parkinsonian patients, and in aged-matched controls
- Trial name
- NCT04592965
- Testing
- Clinical and neuropsychological assessments, Induction of PH and associated bodily states, Resting-state fMRI acquisition
- Where
- 6 sites in Spain, Switzerland
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Olaf Blanke
Post-stroke Arm Spasticity
Arm Spasticity - Non-Interventional Study Early BIRD (BoNT Treatment: Initial and Repeated Documentation)
Botulinum toxin A (BoNT-A) is effective and safe in alleviating post-stroke spasticity and reducing the burden of associated symptoms.
- Trial name
- EARLYBIRD (NCT01840475)
- Where
- 5 sites in Austria, France and 3 more
- Volunteers
- 302 people
- Sponsor
- Ipsen
Pneumonia, Acute Stroke
Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From a Stroke
This study will determine if rhubarb will reduced the incidence of pneumonia and improved recovery from an acute stroke. The study is designed to look at both infection rate and overall recovery and recovery of motor function…
- Trial name
- NCT00789269
- Testing
- rhubarb
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Fudan University
Cervical Dystonia
Phase IV-Cervical Dystonia-INTEREST IN CD2
The purpose of the study is to document long-term response in real-life practice after injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia (Long-term clinical and pharmaco-economic data).
- Trial name
- INTEREST_INCD2 (NCT01753349)
- Testing
- Botulinum toxin type A
- Where
- 113 sites in United States, Algeria and 32 more
- Volunteers
- 1,050 people
- Sponsor
- Ipsen
Rhinoconjunctivitis, Allergic
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis
This study is a mere data collection without predefined intervention. Patients aged 12 years or older who suffer from allergic rhinitis induced by house dust mites, tree pollen or grass pollen and who are treated exclusively with…
- Trial name
- NCT04071249
- Where
- 7 sites in Germany
- Volunteers
- 55 people
- Sponsor
- ClinNovis GmbH
Turner's Syndrome
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
The objective of this study is to evaluate the efficacy and safety of recombinant human growth hormone (r-hGH) treatment in girls with Turner Syndrome under the age of 4 years.
- Trial name
- NCT01066052
- Testing
- r-hGH
- Where
- France
- Volunteers
- 115 people
- Sponsor
- Merck KGaA, Darmstadt, Germany
Postoperative Pain
An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours
To compare the incidence and severity of nausea in the study treatment groups, during the 18-hour period starting 6 hours after titration to pain relief; following confirmation of the assumption of non-inferiority between the two…
- Trial name
- NCT01082471
- Testing
- Morphine 6-glucuronide, Morphine
- Where
- 7 sites in Czechia, France and 4 more
- Volunteers
- 517 people
- Sponsor
- Paion UK Ltd.
Allergy
Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
A phase III study to evaluate the efficacy and safety of SLIT for grass pollen allergens compared with placebo for reduction of symptoms and rescue medication usage in children.
- Trial name
- NCT00409409
- Testing
- 300 IR grass pollen allergen extract tablet
- Where
- Germany
- Volunteers
- 278 people
- Sponsor
- Stallergenes Greer
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.